Articles

A new Joslin Diabetes Center-led study has shown conclusively that a neuropeptide, melanin concentrating hormone (MCH), found in the brain and known for its role in increasing appetite in people, plays a role in the growth of insulin-producing beta cells and the secretion of insulin.

Over-65s who drink four or more caffeinated beverages every day may reduce their risk of heart disease by a whopping 53 per cent, suggests research from the US.

Patients taking the diabetes drug Avandia may have a higher risk of hip and other fractures because the medicine decreases bone formation, according to new research by doctors in New Zealand.

Patients with diabetes undergoing coronary stent implantation for symptomatic acute coronary syndrome have a lower response to a 600-mg dose of clopidogrel, which was linked with a decrease in platelet response.

A new test, called the BIGTT test, simultaneously measures pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.

According to new research from Wake Forest University School of Medicine and colleagues. Up until age 80, older adults not only gain fat as they age – but because of the obesity epidemic – they actually begin their older years fatter.

Adding the diabetes drug Actos to insulin does not improve blood sugar control and may cause weight gain in adolescents who have type 1 diabetes who show signs of insulin resistance.

Magnesium intake in young adults is inversely proportional to the risk for metabolic syndrome, and diabetes according to the results of a prospective study.

Regularly eating a diet supplemented with flaxseed oil may lower blood pressure and reduce risk of cardiovascular disease, according to a new study.

It has been described by Jay Skyler, a leading diabetologist, as the first in a new class of diabetic therapies, “Supra-Rapid Acting Insulin’s”, that can change the way diabetes is treated.